Epilepsy is one of the most impactful diseases on social life. A significant number of epileptic syndromes have been linked to immunological alterations. Elevated levels of antibodies against glutamic acid decarboxylase have been recently found in a significant percentage of patients with temporal lobe epilepsy, the most common epilepsy type. The clinical and pathogenetic relationship of this association is discussed. This link may have important therapeutic implications and merits additional clinical and laboratory research.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10072-011-0566-8 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!